Drug-coated balloon for the treatment of small vessel disease: 9 months of angiographic results and 12 months of clinical outcomes of the PEPCAD China SVD study.
Juying QianYizhe WuChenguang LiJiasheng YinGuosheng FuJian'an WangYong HeGenshan MaYun-Dai ChenYong XiaLang LiFusui JiHesong ZengMeng WeiShaoping NieHuigen JinBen HeYuguo ChenFan LiuHui WangYingxian SunBo XuJunbo Genull nullPublished in: Catheterization and cardiovascular interventions : official journal of the Society for Cardiac Angiography & Interventions (2022)
DCB treatment of de novo SVD was superior to POBA with lower 9-month in-segment LLL. The rates of clinical events were comparable between the two devices.
Keyphrases